Cannapharmarx (CPMD) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CannaPharmaRx has secured the coveted IMC-GAP and GACP certifications, essential for selling cannabis in Israel, a market leader in medical cannabis. These international certifications underscore the company’s commitment to high-quality, safe, and environmentally sound cannabis production. CEO Dean Medwid highlights these milestones as key to the company’s global expansion and imminent product delivery to the Israeli market.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.